Racial/ethnic and gender disparities in the use of erythropoiesis-stimulating agents and blood transfusions: cancer management under Medicare’s reimbursement policy

BACKGROUND: Because of increasing safety concerns related to erythropoiesisstimulating agents (ESAs), the Centers for Medicare & Medicaid Services issued a Medicare reimbursement policy change regarding these medications in cancer patients. However, the policy established an absolute hemoglobin...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Minghui, Schulz, Richard, Chisholm-Burns, Marie, Wang, Junling, Lu, Z. Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390950/
https://www.ncbi.nlm.nih.gov/pubmed/33119441
http://dx.doi.org/10.18553/jmcp.2020.26.11.1477

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10390950/
https://www.ncbi.nlm.nih.gov/pubmed/33119441
http://dx.doi.org/10.18553/jmcp.2020.26.11.1477

Ejemplares similares